Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: Clinical significance in acute non-lymphoblastic leukaemia
- 1 July 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (7) , 882-887
- https://doi.org/10.1016/0277-5379(91)90139-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Postremission chemotherapy in adult acute non-lymphoblastic leukaemia including intensive or non-intensive consolidation therapyEuropean Journal of Cancer and Clinical Oncology, 1991
- Adult acute non‐lymphoblastic leukaemia: reliability and prognostic significance of pretreatment bone marrow S‐phase size determined by flow cytofluorometryScandinavian Journal of Haematology, 1986
- The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometryCytometry, 1985
- Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemiaCytometry, 1985
- Cycling S-Phase Cells in Animal and Spontaneous Tumours: I. Comparison of the BrdUrd and 3H-thymidine techniques and flow cytometry for the estimation of S-phase frequencyActa Radiologica: Oncology, 1985
- Relationship between the per cent of marrow cells in S phase and the outcome of remission‐induction therapy for acute nonlymphocytic leukaemiaBritish Journal of Haematology, 1984
- Sequential vincristine, arabinosylcytosine and adriamycin in acute leukemia: Cytologic and cytokinetic studiesCytometry, 1982
- Short-term treatment for acute myelogenous leukaemia.BMJ, 1982
- A computer program for comparing K samples with right-censored dataComputer Programs in Biomedicine, 1972
- Chemotherapy of acute leukaemiaClinics in Haematology, 1972